SNOA - Sonoma gains on new U.S. EPA designation for disinfectant

Woodstock, Georgia-based Sonoma Pharmaceuticals (NASDAQ:SNOA) and its partner, the MicroSafe Group DMCC announced on Wednesday that Nanocyn hospital grade disinfectant has been included in a list of COVID-19 disinfectants maintained by the U.S. Environmental Protection Agency (EPA). Sonoma (SNOA)shares have added ~8% in reaction. In April, EPA approved Nanocyn for use as a disinfectant in April 2022. The addition to EPA’s List N represents an extension of the prior approval, the company said. EPA’s List N includes products that can destroy the SARS-CoV-2 virus responsible for COVID-19 when used according to the directions. Nanocyn, known as MicroSafe in Europe and West Asia was granted European Standard (EN) 17272 for Airborne Room Disinfection. Last year, Sonoma (SNOA) shares surged on the news that Australia awarded extended approval  for Nanocyn Disinfectant and Sanitizer.

For further details see:

Sonoma gains on new U.S. EPA designation for disinfectant